BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim JS, Lee JY, Yang JW, Lee KH, Effenberger M, Szpirt W, Kronbichler A, Shin JI. Immunopathogenesis and treatment of cytokine storm in COVID-19. Theranostics 2021;11:316-29. [PMID: 33391477 DOI: 10.7150/thno.49713] [Cited by in Crossref: 118] [Cited by in F6Publishing: 84] [Article Influence: 118.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang XD, Ji TT, Dong JR, Feng H, Chen FQ, Chen X, Zhao HY, Chen DK, Ma WT. Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases. Int J Mol Sci 2021;22:13009. [PMID: 34884813 DOI: 10.3390/ijms222313009] [Reference Citation Analysis]
2 Maggi E, Azzarone BG, Canonica GW, Moretta L. What we know and still ignore on COVID-19 immune pathogenesis and a proposal based on the experience of allergic disorders. Allergy 2022;77:1114-28. [PMID: 34582050 DOI: 10.1111/all.15112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Garbo R, Valent F, Gigli GL, Valente M. Pre-Existing Lymphopenia Increases the Risk of Hospitalization and Death after SARS-CoV-2 Infection. Infectious Disease Reports 2022;14:20-5. [DOI: 10.3390/idr14010003] [Reference Citation Analysis]
4 Barrea L, Vetrani C, Caprio M, Cataldi M, Ghoch ME, Elce A, Camajani E, Verde L, Savastano S, Colao A, Muscogiuri G. From the Ketogenic Diet to the Mediterranean Diet: The Potential Dietary Therapy in Patients with Obesity after CoVID-19 Infection (Post CoVID Syndrome). Curr Obes Rep 2022. [PMID: 35524067 DOI: 10.1007/s13679-022-00475-z] [Reference Citation Analysis]
5 Zou M, Su X, Wang L, Yi X, Qiu Y, Yin X, Zhou X, Niu X, Wang L, Su M. The Molecular Mechanism of Multiple Organ Dysfunction and Targeted Intervention of COVID-19 Based on Time-Order Transcriptomic Analysis. Front Immunol 2021;12:729776. [PMID: 34504502 DOI: 10.3389/fimmu.2021.729776] [Reference Citation Analysis]
6 Bi X, Yan X, Jiang B, Liang J, Zhou J, Lu S, Liu J, Luo L, Yin Z. Indoprofen exerts a potent therapeutic effect against sepsis by alleviating high mobility group box 1-mediated inflammatory responses. Toxicol Appl Pharmacol 2021;433:115778. [PMID: 34755645 DOI: 10.1016/j.taap.2021.115778] [Reference Citation Analysis]
7 Hendricks CL, Herd C, Nel M, Tintinger G, Pepper MS. The COVID-19 Treatment Landscape: A South African Perspective on a Race Against Time. Front Med (Lausanne) 2021;8:604087. [PMID: 33681243 DOI: 10.3389/fmed.2021.604087] [Reference Citation Analysis]
8 Luo MH, Qian YQ, Huang DL, Luo JC, Su Y, Wang H, Yu SJ, Liu K, Tu GW, Luo Z. Tailoring glucocorticoids in patients with severe COVID-19: a narrative review. Ann Transl Med 2021;9:1261. [PMID: 34532398 DOI: 10.21037/atm-21-1783] [Reference Citation Analysis]
9 Wei F, Gao C, Wang Y. The role of influenza A virus-induced hypercytokinemia. Crit Rev Microbiol 2021;:1-17. [PMID: 34353210 DOI: 10.1080/1040841X.2021.1960482] [Reference Citation Analysis]
10 Tiyo BT, Schmitz GJH, Ortega MM, da Silva LT, de Almeida A, Oshiro TM, Duarte AJDS. What Happens to the Immune System after Vaccination or Recovery from COVID-19? Life (Basel) 2021;11:1152. [PMID: 34833028 DOI: 10.3390/life11111152] [Reference Citation Analysis]
11 Soy M, Keser G, Atagündüz P. Pathogenesis and treatment of cytokine storm in COVID-19. Turk J Biol 2021;45:372-89. [PMID: 34803441 DOI: 10.3906/biy-2105-37] [Reference Citation Analysis]
12 Fischer L, Barop H, Ludin SM, Schaible HG. Regulation of acute reflectory hyperinflammation in viral and other diseases by means of stellate ganglion block. A conceptual view with a focus on Covid-19. Auton Neurosci 2022;237:102903. [PMID: 34894589 DOI: 10.1016/j.autneu.2021.102903] [Reference Citation Analysis]
13 Udovicic I, Stanojevic I, Djordjevic D, Zeba S, Rondovic G, Abazovic T, Lazic S, Vojvodic D, To K, Abazovic D, Khan W, Surbatovic M. Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19. J Clin Med 2021;10:5815. [PMID: 34945111 DOI: 10.3390/jcm10245815] [Reference Citation Analysis]
14 Lin Z, Niu J, Xu Y, Qin L, Ding J, Zhou L. Clinical efficacy and adverse events of baricitinib treatment for coronavirus disease-2019 (COVID-19): A systematic review and meta-analysis. J Med Virol 2021. [PMID: 34846766 DOI: 10.1002/jmv.27482] [Reference Citation Analysis]
15 Iliadi V, Konstantinidou I, Aftzoglou K, Iliadis S, Konstantinidis TG, Tsigalou C. The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19. Int J Mol Sci 2021;22:5368. [PMID: 34065210 DOI: 10.3390/ijms22105368] [Reference Citation Analysis]
16 Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P, Rezaei-Tavirani M, Rahim F, Gilany K, Mohamadi-Jahani F, Adibi H, Larijani B. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions. Front Cell Dev Biol 2021;9:675310. [PMID: 34195193 DOI: 10.3389/fcell.2021.675310] [Reference Citation Analysis]
17 Joshi C, Jadeja V, Zhou H. Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies. Int J Mol Sci 2021;22:7127. [PMID: 34281182 DOI: 10.3390/ijms22137127] [Reference Citation Analysis]
18 Guo H, Zhou L, Ma Z, Tian Z, Zhou F. Promising Immunotherapies against COVID-19. Adv Ther (Weinh) 2021;:2100044. [PMID: 34179345 DOI: 10.1002/adtp.202100044] [Reference Citation Analysis]
19 Gour A, Manhas D, Bag S, Gorain B, Nandi U. Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2. Phytother Res 2021;35:4258-83. [PMID: 33786876 DOI: 10.1002/ptr.7092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Shang L, Lye DC, Cao B. Contemporary narrative review of treatment options for COVID-19. Respirology 2021;26:745-67. [PMID: 34240518 DOI: 10.1111/resp.14106] [Reference Citation Analysis]
21 Rabaan AA, Al-Ahmed SH, Garout MA, Al-Qaaneh AM, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Hasan A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Emran TB, Bilal M, Singh R, Alyami SA, Moni MA, Dhama K. Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses. Pathogens 2021;10:565. [PMID: 34066983 DOI: 10.3390/pathogens10050565] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
22 Mosalli R, Al Matrafi A, Ghazi MA, Aboumousatafa GA, Paes B. COVID-19 Infection in Spinal Muscular Atrophy Associated with Multisystem Inflammatory Syndrome. Case Rep Pediatr 2021;2021:5862444. [PMID: 34306789 DOI: 10.1155/2021/5862444] [Reference Citation Analysis]
23 Shawki MA, Elsayed NS, Mantawy EM, Said RS. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications. Immunopharmacol Immunotoxicol 2021;43:395-409. [PMID: 34057871 DOI: 10.1080/08923973.2021.1931302] [Reference Citation Analysis]
24 Cavezzi A, Menicagli R, Troiani E, Corrao S. COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis. F1000Res 2022;11:102. [DOI: 10.12688/f1000research.108667.1] [Reference Citation Analysis]
25 Wang Y, Wu M, Li Y, Yuen HH, He ML. The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy. J Biomed Sci 2022;29:27. [PMID: 35505345 DOI: 10.1186/s12929-022-00811-4] [Reference Citation Analysis]
26 Toda M, Fujii K, Yoshifuji A, Kondo Y, Itoh K, Sekine K, Kikuchi T, Ryuzaki M. Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients. Clin Exp Nephrol 2021. [PMID: 34436742 DOI: 10.1007/s10157-021-02126-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kralj M, Jakovac H. Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report. Clin Case Rep 2021. [PMID: 33821193 DOI: 10.1002/ccr3.4010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
28 García-García JA, Pérez-Quintana M, Ramos-Giráldez C, Cebrián-González I, Martín-Ponce ML, Del Valle-Villagrán J, Navarro-Puerto MA, Sánchez-Villegas J, Gómez-Herreros R, Manoja-Bustos I, León-Martí D, Serrano-Rodríguez L, de Miguel-Albarreal A, Velasco-Romero MJ, Mula-Falcón F, Fernández-Pérez P, Melguizo-Moya I, Pérez-Quintana MJ, Romero-Molina G, Vergara-López S, Marenco-de la Fuente JL, Marín-Martín J, Mira-Escarti JA. Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19. J Clin Med 2021;10:4019. [PMID: 34501467 DOI: 10.3390/jcm10174019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ahmed Mostafa G, Mohamed Ibrahim H, Al Sayed Shehab A, Mohamed Magdy S, Aboabdoun Soliman N, Fathy El-sherif D. Up-regulated serum levels of interleukin (IL)-17A and IL-22 in Egyptian pediatric patients with COVID-19 and MIS-C: Relation to the disease outcome. Cytokine 2022;154:155870. [DOI: 10.1016/j.cyto.2022.155870] [Reference Citation Analysis]
30 Zheng Y, Li S, Song K, Ye J, Li W, Zhong Y, Feng Z, Liang S, Cai Z, Xu K. A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses. Viruses 2022;14:928. [DOI: 10.3390/v14050928] [Reference Citation Analysis]
31 Han X, Li X, Xiao Y, Yang R, Wang Y, Wei X. Distinct Characteristics of COVID-19 Infection in Children. Front Pediatr 2021;9:619738. [PMID: 33748041 DOI: 10.3389/fped.2021.619738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Yan T, Xiao R, Wang N, Shang R, Lin G. Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities. Theranostics 2021;11:8234-53. [PMID: 34373739 DOI: 10.7150/thno.59293] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
33 Gomaa AA, Mohamed HS, Abd-Ellatief RB, Gomaa MA. Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly. Inflammopharmacology 2021;29:1033-48. [PMID: 34224069 DOI: 10.1007/s10787-021-00841-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 You J, Li H, Fan P, Yang X, Wei Y, Zheng L, Li Z, Yi C. Inspiration for COVID-19 Treatment: Network Analysis and Experimental Validation of Baicalin for Cytokine Storm. Front Pharmacol 2022;13:853496. [PMID: 35350754 DOI: 10.3389/fphar.2022.853496] [Reference Citation Analysis]
35 Rana P, Chauhan S, Mubayi A. Burden of cytokines storm on prognosis of SARS-CoV-2 infection through immune response: dynamic analysis and optimal control with immunomodulatory therapy. Eur Phys J Spec Top . [DOI: 10.1140/epjs/s11734-022-00435-7] [Reference Citation Analysis]
36 Sibilio P, Bini S, Fiscon G, Sponziello M, Conte F, Pecce V, Durante C, Paci P, Falcone R, Norata GD, Farina L, Verrienti A. In silico drug repurposing in COVID-19: A network-based analysis. Biomed Pharmacother 2021;142:111954. [PMID: 34358753 DOI: 10.1016/j.biopha.2021.111954] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Li H, You J, Yang X, Wei Y, Zheng L, Zhao Y, Huang Y, Jin Z, Yi C. Glycyrrhetinic acid: A potential drug for the treatment of COVID-19 cytokine storm. Phytomedicine 2022;102:154153. [PMID: 35636166 DOI: 10.1016/j.phymed.2022.154153] [Reference Citation Analysis]
38 Rochette L, Ghibu S. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection. Int J Mol Sci 2021;22:7979. [PMID: 34360751 DOI: 10.3390/ijms22157979] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Koenis DS, Beegun I, Jouvene CC, Aguirre GA, Souza PR, Gonzalez-Nunez M, Ly L, Pistorius K, Kocher HM, Ricketts W, Thomas G, Perretti M, Alusi G, Pfeffer P, Dalli J. Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19. Circ Res 2021;129:e54-71. [PMID: 34238021 DOI: 10.1161/CIRCRESAHA.121.319142] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Romano A, Cerchione C, Conticello C, Filetti S, Bulla A, Chiarenza A, Del Fabro V, Leotta S, Markovic U, Motta G, Parisi M, Stagno F, Palumbo GA, Di Raimondo F. Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection. Cancers (Basel) 2022;14:1173. [PMID: 35267478 DOI: 10.3390/cancers14051173] [Reference Citation Analysis]
41 Brox R, Achenbach S, Hackstein H. Detection of SARS-CoV-2-independent immunoregulatory activity of COVID-19 convalescent plasma. Transfusion 2021;61:3087-93. [PMID: 34546583 DOI: 10.1111/trf.16685] [Reference Citation Analysis]
42 Primorac D, Čemerin M, Matišić V, Molnar V, Strbad M, Girandon L, Zenić L, Knežević M, Minger S, Polančec D. Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment. Pharmaceutics 2021;13:1481. [PMID: 34575557 DOI: 10.3390/pharmaceutics13091481] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Ferrari D, Rubini M, Burns JS. The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2. Front Immunol 2022;13:904419. [DOI: 10.3389/fimmu.2022.904419] [Reference Citation Analysis]
44 Murdaca G, Paladin F, Tonacci A, Isola S, Allegra A, Gangemi S. The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic. Biomedicines 2021;9:1688. [PMID: 34829918 DOI: 10.3390/biomedicines9111688] [Reference Citation Analysis]
45 Banerjee I, Robinson J, Sathian B. Corticosteroid induced avascular necrosis and COVID-19: The drug dilemma. Nepal J Epidemiol 2021;11:1049-52. [PMID: 34733566 DOI: 10.3126/nje.v11i3.39309] [Reference Citation Analysis]
46 Paul S, Bravo Vázquez LA, Reyes-Pérez PR, Estrada-Meza C, Aponte Alburquerque RA, Pathak S, Banerjee A, Bandyopadhyay A, Chakraborty S, Srivastava A. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review. Virus Res 2021;308:198631. [PMID: 34788642 DOI: 10.1016/j.virusres.2021.198631] [Reference Citation Analysis]
47 Marino FE, Vargas NT, Skein M, Hartmann T. Metabolic and inflammatory health in SARS-CoV-2 and the potential role for habitual exercise in reducing disease severity. Inflamm Res 2021. [PMID: 34719732 DOI: 10.1007/s00011-021-01517-3] [Reference Citation Analysis]
48 Li J, Long X, Zhang Q, Fang X, Luo H, Fang F, Lv X, Zhang D, Sun Y, Li N, Hu S, Li J, Xiong N, Lin Z. Pearson's patterns correlational of clinical risks at admissions with hospitalization outcomes during initial COVID-19 outbreak. iScience 2022;25:104415. [PMID: 35600840 DOI: 10.1016/j.isci.2022.104415] [Reference Citation Analysis]
49 Saavedra-Romero R, Paz F, Litell JM, Weinkauf J, Benson CC, Tindell L, Williams K. Treatment of Severe Hypercapnic Respiratory Failure Caused by SARS-CoV-2 Lung Injury with ECCO2R Using the Hemolung Respiratory Assist System. Case Rep Crit Care 2021;2021:9958343. [PMID: 34327027 DOI: 10.1155/2021/9958343] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Cavezzi A, Menicagli R, Troiani E, Corrao S. COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis. F1000Res 2022;11:102. [DOI: 10.12688/f1000research.108667.2] [Reference Citation Analysis]
51 Zhang C, Wang X, Wang C, He C, Ma Q, Li J, Wang W, Xu YT, Wang T. Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation. Front Pharmacol 2021;12:790072. [PMID: 35002723 DOI: 10.3389/fphar.2021.790072] [Reference Citation Analysis]
52 Manik M, Singh RK. Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19. J Med Virol 2021. [PMID: 34672376 DOI: 10.1002/jmv.27405] [Reference Citation Analysis]
53 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Reference Citation Analysis]
54 Trotta L, Pancrazi M, Bizzi E, Tombetti E, Mascolo R, Pallini G, Syed AB, Lewinter M, Klein A, Brucato AL. Use of rilonacept in patients with recurrent pericarditis during COVID-19 disease. Expert Opin Biol Ther 2022. [PMID: 35486483 DOI: 10.1080/14712598.2022.2072210] [Reference Citation Analysis]
55 Sayed AI, Mansour YE, Ali MA, Aly O, Khoder ZM, Said AM, Fatahala SS, Abd El-Hameed RH. Novel pyrrolopyrimidine derivatives: design, synthesis, molecular docking, molecular simulations and biological evaluations as antioxidant and anti-inflammatory agents. J Enzyme Inhib Med Chem 2022;37:1821-37. [PMID: 35762086 DOI: 10.1080/14756366.2022.2090546] [Reference Citation Analysis]
56 Zheng J, Miao J, Guo R, Guo J, Fan Z, Kong X, Gao R, Yang L. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2. Front Cell Infect Microbiol 2022;12:931061. [DOI: 10.3389/fcimb.2022.931061] [Reference Citation Analysis]
57 Pelaia C, Calabrese C, Garofalo E, Bruni A, Vatrella A, Pelaia G. Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. Int J Mol Sci 2021;22:3059. [PMID: 33802761 DOI: 10.3390/ijms22063059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
58 Zhao Y, Sui L, Wu P, Wang W, Wang Z, Yu Y, Hou Z, Tan G, Liu Q, Wang G. A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response. Signal Transduct Target Ther 2021;6:331. [PMID: 34471099 DOI: 10.1038/s41392-021-00742-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Muhammad A, Forcados GE, Sani H, Ndidi US, Adamu A, Katsayal BS, Sadiq IZ, Abubakar YS, Sulaiman I, Abubakar IB, Yusuf AP, Malami I, Ibrahim S, Abubakar MB. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID‐19. Journal of Food Biochemistry. [DOI: 10.1111/jfbc.14079] [Reference Citation Analysis]
60 Chan KKP, Hui DSC. Contemporary Concise Review 2021: COVID-19 and other respiratory infections. Respirology 2022. [PMID: 35670259 DOI: 10.1111/resp.14305] [Reference Citation Analysis]
61 Khamis Hussein S, Magdy Yousef R, Mohammed MM, Yehia Abdelwahed M, Ahmed Mohammed R. COVID-19 in Children: Clinical Presentations and Outcomes in Fayoum Governorate, Egypt. Arch Pediatr Infect Dis 2021;In Press. [DOI: 10.5812/pedinfect.112798] [Reference Citation Analysis]
62 Kronbichler A, Geetha D, Smith RM, Egan AC, Bajema IM, Schönermarck U, Mahr A, Anders HJ, Bruchfeld A, Cid MC, Jayne DRW. The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum. Autoimmun Rev 2021;:102986. [PMID: 34718165 DOI: 10.1016/j.autrev.2021.102986] [Reference Citation Analysis]
63 Rosenberg HF, Foster PS. Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies. Semin Immunopathol 2021;43:383-92. [PMID: 33728484 DOI: 10.1007/s00281-021-00850-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
64 Jung SY, Kim MS, Li H, Lee KH, Koyanagi A, Solmi M, Kronbichler A, Dragioti E, Tizaoui K, Cargnin S, Terrazzino S, Hong SH, Abou Ghayda R, Kim NK, Chung SK, Jacob L, Salem JE, Yon DK, Lee SW, Kostev K, Kim AY, Jung JW, Choi JY, Shin JS, Park SJ, Choi SW, Ban K, Moon SH, Go YY, Shin JI, Smith L. Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database. Clin Transl Sci 2021. [PMID: 34719115 DOI: 10.1111/cts.13168] [Reference Citation Analysis]
65 Alturaiki W, Mubarak A, Al Jurayyan A, Hemida MG. The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2. Hum Vaccin Immunother 2021;17:3297-309. [PMID: 34114940 DOI: 10.1080/21645515.2021.1935172] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Hu T, Tang C, Stern S, Yang L, Du T. 17α-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-κB Activation. Front Pharmacol 2022;13:831315. [PMID: 35330839 DOI: 10.3389/fphar.2022.831315] [Reference Citation Analysis]
67 Dotan A, David P, Arnheim D, Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun Rev 2022;:103071. [PMID: 35182777 DOI: 10.1016/j.autrev.2022.103071] [Reference Citation Analysis]
68 Kumboyono K, Chomsy IN, Iskandar A, Aryati A, Parwati I, Wihastuti TA. The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival. IDR 2022;Volume 15:821-9. [DOI: 10.2147/idr.s348392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Zou Y, Han M, Wang J, Zhao J, Gan H, Yang Y. Predictive value of frailty in the mortality of hospitalized patients with COVID-19: a systematic review and meta-analysis. Ann Transl Med 2022;10:166. [PMID: 35280387 DOI: 10.21037/atm-22-274] [Reference Citation Analysis]
70 Sygitowicz G, Maciejak-jastrzębska A, Sitkiewicz D. The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases. Biomolecules 2022;12:46. [DOI: 10.3390/biom12010046] [Reference Citation Analysis]
71 Chen S, Wang X, Ha D, Yoshitake R. White Button Mushroom (Agaricus bisporus) Interrupts Tissue AR-TMPRSS2 Expression and Attenuates Pro-inflammatory Cytokines in C57BL/6 Mice: Implication for COVID-19 Dietary Intervention. Res Sq 2021:rs. [PMID: 33791688 DOI: 10.21203/rs.3.rs-244245/v1] [Reference Citation Analysis]
72 Chen PK, Lan JL, Huang PH, Hsu JL, Chang CK, Tien N, Lin HJ, Chen DY. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19. Front Immunol 2021;12:719544. [PMID: 34367188 DOI: 10.3389/fimmu.2021.719544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Alkattan W, Yaqinuddin A, Shafqat A, Kashir J. NET-Mediated Pathogenesis of COVID-19: The Role of NETs in Hepatic Manifestations. Journal of Health and Allied Sciences NU. [DOI: 10.1055/s-0041-1741418] [Reference Citation Analysis]
74 Jankowski J, Lee HK, Wilflingseder J, Hennighausen L. JAK inhibitors dampen activation of interferon-activated transcriptomes and the SARS-CoV-2 receptor ACE2 in human renal proximal tubules. iScience 2021;24:102928. [PMID: 34345808 DOI: 10.1016/j.isci.2021.102928] [Reference Citation Analysis]
75 Deodhar A, Bhana S, Winthrop K, Gensler LS. COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis. Rheumatol Ther. [DOI: 10.1007/s40744-022-00462-9] [Reference Citation Analysis]
76 Wang X, Ha D, Yoshitake R, Chen S. White button mushroom interrupts tissue AR-mediated TMPRSS2 expression and attenuates pro-inflammatory cytokines in C57BL/6 mice. NPJ Sci Food 2021;5:20. [PMID: 34341347 DOI: 10.1038/s41538-021-00102-6] [Reference Citation Analysis]
77 Yulistiani, Izka A H, Rindang A M, A W P. Tocilizumab therapy in COVID-19 patients. PE. [DOI: 10.46542/pe.2022.222.259262] [Reference Citation Analysis]
78 Wang L, Li Y, Xu M, Deng Z, Zhao Y, Yang M, Liu Y, Yuan R, Sun Y, Zhang H, Wang H, Qian Z, Kang H. Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells. Front Immunol 2021;12:726909. [PMID: 34394132 DOI: 10.3389/fimmu.2021.726909] [Reference Citation Analysis]
79 Bektaş M, Özdemir G. Protracted or recurrent COVID-19 associated cytokine storm in a patient with chronic lymphocytic leukemia receiving rituximab-based chemotherapy. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.108936] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Alves HR, Lomba GSB, Gonçalves-de-albuquerque CF, Burth P. Irisin, Exercise, and COVID-19. Front Endocrinol 2022;13:879066. [DOI: 10.3389/fendo.2022.879066] [Reference Citation Analysis]
81 Karatas E, Aksoy L, Ozaslan E. Association of Early Favipiravir Use with Reduced COVID-19 Fatality among Hospitalized Patients. Infect Chemother 2021;53:300-7. [PMID: 34216123 DOI: 10.3947/ic.2020.0149] [Reference Citation Analysis]
82 Chen Y, Zhuang Z, Yang J, Bai L. Screening of Microbial Natural Products and Biological Evaluation of Trichomicin as Potential Anti-Cytokine Storm Agents. Front Pharmacol 2021;12:770910. [PMID: 34955842 DOI: 10.3389/fphar.2021.770910] [Reference Citation Analysis]
83 Lee S, Na HG, Choi YS, Bae CH, Song S, Kim Y, Ashwood P. SARS-CoV-2 Induces Expression of Cytokine and MUC5AC/5B in Human Nasal Epithelial Cell through ACE 2 Receptor. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/2743046] [Reference Citation Analysis]
84 Kim KM, Kim SY, Mony TJ, Bae HJ, Han SD, Lee ES, Choi SH, Hong SH, Lee SD, Park SJ. Dracocephalum moldavica Ethanol Extract Suppresses LPS-Induced Inflammatory Responses through Inhibition of the JNK/ERK/NF-κB Signaling Pathway and IL-6 Production in RAW 264.7 Macrophages and in Endotoxic-Treated Mice. Nutrients 2021;13:4501. [PMID: 34960054 DOI: 10.3390/nu13124501] [Reference Citation Analysis]
85 Rowaiye AB, Okpalefe OA, Onuh Adejoke O, Ogidigo JO, Hannah Oladipo O, Ogu AC, Oli AN, Olofinase S, Onyekwere O, Rabiu Abubakar A, Jahan D, Islam S, Dutta S, Haque M. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J Inflamm Res 2021;14:1487-510. [PMID: 33889008 DOI: 10.2147/JIR.S301784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
86 Li W, Li D, Chen Y, Abudou H, Wang H, Cai J, Wang Y, Liu Z, Liu Y, Fan H. Classic Signaling Pathways in Alveolar Injury and Repair Involved in Sepsis-Induced ALI/ARDS: New Research Progress and Prospect. Dis Markers 2022;2022:6362344. [PMID: 35726235 DOI: 10.1155/2022/6362344] [Reference Citation Analysis]
87 Hernández-Huerta MT, Pérez-Santiago AD, Pérez-Campos Mayoral L, Sánchez Navarro LM, Rodal Canales FJ, Majluf-Cruz A, Matias-Cervantes CA, Pérez-Campos Mayoral E, Romero Díaz C, Mayoral-Andrade G, Martínez Cruz M, Luna Ángel J, Pérez-Campos E. Mechanisms of Immunothrombosis by SARS-CoV-2. Biomolecules 2021;11:1550. [PMID: 34827548 DOI: 10.3390/biom11111550] [Reference Citation Analysis]
88 Giordo R, Zinellu A, Eid AH, Pintus G. Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders. Molecules 2021;26:856. [PMID: 33562030 DOI: 10.3390/molecules26040856] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
89 Kuśnierz-Cabala B, Maziarz B, Dumnicka P, Dembiński M, Kapusta M, Bociąga-Jasik M, Winiarski M, Garlicki A, Grodzicki T, Kukla M. Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19-A Preliminary Study. Biomolecules 2021;11:1136. [PMID: 34439802 DOI: 10.3390/biom11081136] [Reference Citation Analysis]
90 Zhang X, Shang L, Fan G, Gu X, Xu J, Wang Y, Huang L, Cao B. The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:800492. [PMID: 35155477 DOI: 10.3389/fmed.2021.800492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Li Y, Li B, Wang P, Wang Q. Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production via NF-κB Signaling Pathway in Macrophages: Implications for Coronavirus Disease 2019 (COVID-19) Therapy. Front Pharmacol 2021;12:722126. [PMID: 34764867 DOI: 10.3389/fphar.2021.722126] [Reference Citation Analysis]
92 Fedullo AL, Schiattarella A, Morlando M, Raguzzini A, Toti E, De Franciscis P, Peluso I. Mediterranean Diet for the Prevention of Gestational Diabetes in the Covid-19 Era: Implications of Il-6 In Diabesity. Int J Mol Sci 2021;22:1213. [PMID: 33530554 DOI: 10.3390/ijms22031213] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
93 Abdullayev R, Gul F, Bilgili B, Seven S, Cinel I. Cytokine Adsorption in Critically Ill COVID-19 Patients, a Case-Control Study. J Intensive Care Med. [DOI: 10.1177/08850666221085185] [Reference Citation Analysis]
94 Haskologlu IC, Erdag E, Sayiner S, Abacioglu N, Sehirli AO. Melatonin and REGN-CoV2 combination as a vaccine adjuvant for Omicron variant of SARS-CoV-2. Mol Biol Rep 2022. [PMID: 35389130 DOI: 10.1007/s11033-022-07419-9] [Reference Citation Analysis]
95 Rana MM. Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges. J Biomater Sci Polym Ed 2021;32:1219-49. [PMID: 33787467 DOI: 10.1080/09205063.2021.1909412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]